Intrinsiqs

Is Allogene Therapeutics, Inc. overvalued?

Allogene Therapeutics, Inc. (ALLO) — key valuation metrics and fundamentals.

No verdict
Price
$2.05
Fair value
Current P/E
Normal P/E
Market cap
$707.6M
Dividend yield
0.0%
Return on equity
-56.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ALLO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.